These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9282176)

  • 1. A rapid screening procedure for the identification of high-titer retrovirus packaging clones.
    Murdoch B; Pereira DS; Wu X; Dick JE; Ellis J
    Gene Ther; 1997 Jul; 4(7):744-9. PubMed ID: 9282176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorting vector producer cells for high transgene expression increases retroviral titer.
    Beaudoin EL; Bais AJ; Junghans RP
    J Virol Methods; 2008 Mar; 148(1-2):253-9. PubMed ID: 18249448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
    J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid procedure for screening fibroblast packaging cell lines for secretion of selectable retrovirus.
    Elefanty AG; Cory S
    Biotechniques; 1993 May; 14(5):770-4. PubMed ID: 8512701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sorting of packaging cells for retroviral vector carrying green fluorescent gene and viral titer determination].
    Zhang YG; Guo X; Zhou JJ; Yu B; Liu B
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):30-2, 36. PubMed ID: 15683992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Packaging and concentrating of high titer of retrovirus containing IL-4RA].
    Wang GL; Liu XT; Lu JR
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):761-4. PubMed ID: 19755029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retroviral-mediated transfer of beta-globin gene into human hematopoietic cells].
    Gao C; Xu Y; Zhang J; Liu D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Oct; 18(5):353-7. PubMed ID: 9388961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
    J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One step screening of retroviral producer clones by real time quantitative PCR.
    Towers GJ; Stockholm D; Labrousse-Najburg V; Carlier F; Danos O; Pagès JC
    J Gene Med; 1999; 1(5):352-9. PubMed ID: 10738552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
    Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
    Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of transient expression system for retroviral vector production.
    Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
    J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay.
    Green BJ; Rasko JE
    Hum Gene Ther; 2002 Jun; 13(9):1005-13. PubMed ID: 12067434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
    Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
    Hanazono Y; Yu JM; Dunbar CE; Emmons RV
    Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture.
    Wu SC; Huang GY; Liu JH
    Biotechnol Prog; 2002; 18(3):617-22. PubMed ID: 12052081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
    Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple and reliable method for screening retroviral producer clones without selectable markers.
    Onodera M; Yachie A; Nelson DM; Welchlin H; Morgan RA; Blaese RM
    Hum Gene Ther; 1997 Jul; 8(10):1189-94. PubMed ID: 9215736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.